FIELD: medicine, pediatry. SUBSTANCE: method involves administration of 2% alpha-tocopherol in 50% dimexide solution by electrophoresis for 6-7 days followed by determination of blood chemiluminescence. Electrophoresis is ceased at value of total chemiluminescence light 5.7 quantum/min x 106 and less. EFFECT: high effectiveness, rapid normalization of neurological status indices, absence of traumatism. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PROGNOSIS OF BACTERIAL COMPLICATIONS IN NEWBORNS | 1995 |
|
RU2102753C1 |
METHOD FOR PREDICTING ENCEPHALOPATHY IN NEONATALS | 2004 |
|
RU2254573C1 |
METHOD OF TREATING PERINATAL AFFECTION OF CENTRAL NERVOUS SYSTEM IN NEWBORNS IN CRITICAL STATE | 2008 |
|
RU2387369C1 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF MYOCARDIUM DAMAGE IN NEWBORNS | 1994 |
|
RU2089900C1 |
METHOD OF DIAGNOSIS OF RESPIRATORY DISTRESS SYNDROME IN NEWBORNS | 1991 |
|
RU2021209C1 |
METHOD FOR PREDICTING CENTRAL NERVOUS SYSTEM DISORDERS IN NEWBORNS BELONGING TO PERINATAL RISK GROUP | 2004 |
|
RU2276365C1 |
METHOD OF DIAGNOSING IN-LABOR INTRACRANIAL HEMORRHAGE IN NEONATES | 1991 |
|
RU2012879C1 |
METHOD OF PROGNOSTICATION OF HYPERTENSION SYNDROME ON NEWBORNS | 1996 |
|
RU2135072C1 |
METHOD FOR DETERMINATION OF CHILDREN NEUROLOGICAL DISEASES TREATMENT EFFICACY | 0 |
|
SU1762899A1 |
METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF SUBEPENDYMOUS AND INTRAVENTRICULAR HEMORRHAGES | 1999 |
|
RU2173852C2 |
Authors
Dates
1997-09-10—Published
1995-09-27—Filed